Definition and regulatory position
A classical formula preparation is a modern medicinal product developed from a fixed traditional Chinese medicine formula with an identifiable source in an ancient medical text, following textual research, pharmaceutical development, and regulatory review. It belongs to WSIC 2.1.2. In this entry, “classical” specifically refers to the Chinese ancient classical prescription framework and its regulatory context. It does not include every old folk remedy, inherited family recipe, or prescription from another traditional medical system. Ingredients can be of botanical, animal, or mineral origin, so the category is also distinct from a traditional herbal medicinal product that contains only botanical active ingredients.
China's current registration classification separates preparations managed under the national catalogue of ancient classical prescriptions from other preparations derived from classical prescriptions. The latter group includes non-catalogued formulas and products modified by adding or removing ingredients from an ancient formula. The two routes have different dossier requirements and cannot be treated as interchangeable because their names resemble one another. They are also distinct from an individualized decoction prepared during clinical care, an assembly of single-herb dispensing granules, an institutional preparation, an existing same-name-and-formula medicine, or a health food. Placement in the WSIC catalogue is a knowledge-indexing decision and does not determine prescription or nonprescription status in a place of sale.
Textual source and critical-information research
Translation of an ancient formula into a registered prescription begins by fixing the title of the source text, dynasty, author, edition, and original passage. Research then has to resolve the formula name, ingredient names, biological or mineral origin, medicinal part, processing, quantities, method of preparation, route, administration, and functions and indications. Ancient units cannot be converted into modern grams by reading the numerals literally. The same historical ingredient name may also have referred to different species, parts, or processed materials at different times. A catalogue-managed candidate should follow the official catalogue and published critical-information table; unresolved or unpublished details cannot be supplied by advertising copy.
The result must be a bounded prescription and method that can be repeated. Replacing an ingredient, adding or removing components, changing the daily amount of prepared slices, changing the route, or expanding the indication may move a product outside the original catalogue item. A shared formula name does not remove the need to evaluate it under the applicable registration route. Historical indications should be rendered in standardized TCM terminology. A syndrome description cannot simply be converted into every patient with a modern disease label, and words conventionally translated as calming the spirit or sleeplessness do not make the product suitable for every sleep-onset or sleep-maintenance complaint.
Reference samples and conversion to a modern dosage form
Reference samples turn the researched prescription, quality of raw materials and prepared slices, traditional method, and resulting medicinal substance into measurable physical comparators. Work on a decoction should define order of addition, water quantity, soaking, vessel, heating, time, number of decoctions, filtration, and concentration. Powders, pills, pastes, and other historical forms should retain the logic of their own methods rather than being forced into a decoction model. Representative batches can characterize expected variation and establish ranges for extract yield, solids, characteristic chromatograms, and multiple constituent measurements.
The modern product also needs a justified dosage form, conversion of the daily amount, excipients, forming and drying process, package, and directions. Converting a decoction to granules or industrializing another traditional form is not merely compressing one daily set of prepared slices into one sachet. Concentration, drying, and added excipients change how quality is expressed. Correlation studies should follow the material from raw drugs and prepared slices through reference samples and intermediates to the finished product, showing how important constituents and the overall profile are transferred and controlling unacceptable loss, formation, or drift. Similar appearance, total extractables, or one passing marker assay cannot alone establish correspondence to the original medicinal substance.
Raw materials, manufacture, and lifecycle quality
Each raw drug and prepared slice should meet the applicable standard and be traceable to its origin, production area, harvest or husbandry, processing, and preparation batch. Quality work has to address authenticity, geographic and annual variation, degree of processing, water content, insects and mould, microorganisms, mycotoxins, pesticide residues, heavy metals, and risks specific to each ingredient. A multi-ingredient formula should not be controlled only through the easiest component to measure. Specific identification, characteristic or fingerprint profiles, and multicomponent control should cover the formula and important process changes as far as practicable.
Manufacturing controls should define critical parameters and ranges for extraction or preparation, solid-liquid separation, concentration, drying, blending, and dosage-form production. They should guard against loss of volatile constituents, thermal degradation, discarded precipitates, cross-contamination, and nonuniform blending. Finished-product specifications also need relevant controls for dose or fill variation, disintegration or dissolution, microbial limits, package compatibility, and stability over shelf life. A change in source, supplier, processing method, equipment scale, process parameter, or package requires assessment of its effect on reference-sample correlation and the established safety and efficacy boundary. An approved process and internal specification cannot be rewritten merely for manufacturing convenience.
Indications and interpretation of evidence
Catalogue inclusion, an ancient text, history of human use, pharmaceutical comparability, nonclinical safety, and modern clinical studies are different forms of evidence. The current framework sets different dossier requirements for catalogue-managed class 3.1 products and other class 3.2 products derived from classical formulas. A qualifying pathway may reduce particular study requirements, but that is a regulatory arrangement tied to a defined prescription, method, and use history. It does not mean that efficacy for a modern diagnosis has been established in randomized comparative trials, and it does not prove superiority to another treatment. The approved scope is ultimately the scope in the leaflet of the specific finished product.
Sleep-related evaluation should record the approved TCM syndrome together with sleep-onset latency, awakenings, total sleep time, perceived sleep quality, next-day function, and adverse reactions. Drowsiness after a dose or a general feeling of calm is not a sufficient outcome. Results for one fixed product do not automatically apply to a home decoction with the same formula name, a combination of single-herb granules, a product with different processing or dose, or another classical formula. Historical case records and commentaries can explain the theoretical lineage, but they do not replace scrutiny of study design, controls, sample size, attrition, concurrent care, and long-term risks.
Professional use, safety, and interactions
A finished classical formula has a fixed prescription and is not the same as an individualized prescription that a qualified practitioner may modify after assessment. Use requires the exact approval number, full composition, daily amount of every prepared ingredient, functions and indications, dosage, duration, contraindications, and precautions. Under the current package-insert guidance, an ancient classical formula preparation is generally identified as a prescription medicine for TCM clinical use unless otherwise specified. An ancient passage, an online formula explanation, or a label from a similar product must therefore not be used as authority for self-prescribing or changing ingredients.
When another Chinese patent medicine, decoction, health product, or conventional medicine is used, all ingredients should be fully enumerated and checked for duplicate drugs, cumulative dose, traditional incompatibilities, and possible pharmacodynamic or pharmacokinetic interactions. Pregnancy and breastfeeding, childhood, older age, hepatic or renal impairment, allergy, and the perioperative period require formula-specific assessment. “Ancient,” “natural,” and “processed” do not mean risk-free. A severe rash, breathing difficulty, jaundice, altered consciousness, marked palpitations, or another significant reaction warrants discontinuation and medical care. The product, leaflet, and batch number should be retained for a pharmacovigilance report.
Selection, follow-up, and sleep-medicine boundaries
Selection should begin with verification of the exact medicinal-product name, approval number, marketing authorization holder, manufacturer, dosage form, strength, and leaflet in the competent authority's database. A name found in an old text, a claimed inherited version, a decoction service, or a cross-border sales page is not a substitute for product identity. Dose timing, a sleep diary, relevant syndrome features, daytime function, and adverse effects can be recorded during use and reviewed at the point specified by the leaflet or prescriber. Lack of improvement, repeated dose escalation, or recurrence whenever a product is stopped should not lead to unsupervised cycling among classical formulas.
Persistent insomnia, substantial daytime impairment, loud snoring or witnessed pauses in breathing, unusual sleep behaviors, distressing leg sensations, mania, severe depression, or self-harm risk requires appropriate sleep or mental-health assessment. A classical formula preparation does not replace sleep-apnea treatment, cognitive behavioral therapy for insomnia, or urgent care. It should not claim to cure insomnia, fit every syndrome, have no interactions, or be absolutely safe because it has a long history. Authentic historical provenance, pharmaceutical quality, lawful approval, clinical efficacy, and suitability for one patient are five separate questions.